Global Alpha-fetoprotein (AFP) Tumor Market Size, Status and Forecast 2021-2027
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Alpha-fetoprotein (AFP) Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
- 1.2.2 Liver Cancer
- 1.2.3 Testes Cancer
- 1.2.4 Ovarian Cancer
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Alpha-fetoprotein (AFP) Tumor Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Screening and Early Detection
- 1.3.3 Diagnosis
- 1.3.4 Prognosis
- 1.3.5 Post Treatment Monitoring
- 1.3.6 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Alpha-fetoprotein (AFP) Tumor Market Perspective (2016-2027)
- 2.2 Alpha-fetoprotein (AFP) Tumor Growth Trends by Regions
- 2.2.1 Alpha-fetoprotein (AFP) Tumor Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 Alpha-fetoprotein (AFP) Tumor Historic Market Share by Regions (2016-2021)
- 2.2.3 Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Regions (2022-2027)
- 2.3 Alpha-fetoprotein (AFP) Tumor Industry Dynamic
- 2.3.1 Alpha-fetoprotein (AFP) Tumor Market Trends
- 2.3.2 Alpha-fetoprotein (AFP) Tumor Market Drivers
- 2.3.3 Alpha-fetoprotein (AFP) Tumor Market Challenges
- 2.3.4 Alpha-fetoprotein (AFP) Tumor Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Alpha-fetoprotein (AFP) Tumor Players by Revenue
- 3.1.1 Global Top Alpha-fetoprotein (AFP) Tumor Players by Revenue (2016-2021)
- 3.1.2 Global Alpha-fetoprotein (AFP) Tumor Revenue Market Share by Players (2016-2021)
- 3.2 Global Alpha-fetoprotein (AFP) Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Alpha-fetoprotein (AFP) Tumor Revenue
- 3.4 Global Alpha-fetoprotein (AFP) Tumor Market Concentration Ratio
- 3.4.1 Global Alpha-fetoprotein (AFP) Tumor Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Alpha-fetoprotein (AFP) Tumor Revenue in 2020
- 3.5 Alpha-fetoprotein (AFP) Tumor Key Players Head office and Area Served
- 3.6 Key Players Alpha-fetoprotein (AFP) Tumor Product Solution and Service
- 3.7 Date of Enter into Alpha-fetoprotein (AFP) Tumor Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-fetoprotein (AFP) Tumor Breakdown Data by Type
- 4.1 Global Alpha-fetoprotein (AFP) Tumor Historic Market Size by Type (2016-2021)
- 4.2 Global Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Type (2022-2027)
5 Alpha-fetoprotein (AFP) Tumor Breakdown Data by Application
- 5.1 Global Alpha-fetoprotein (AFP) Tumor Historic Market Size by Application (2016-2021)
- 5.2 Global Alpha-fetoprotein (AFP) Tumor Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America Alpha-fetoprotein (AFP) Tumor Market Size (2016-2027)
- 6.2 North America Alpha-fetoprotein (AFP) Tumor Market Size by Type
- 6.2.1 North America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2021)
- 6.2.2 North America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2022-2027)
- 6.2.3 North America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2027)
- 6.3 North America Alpha-fetoprotein (AFP) Tumor Market Size by Application
- 6.3.1 North America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2021)
- 6.3.2 North America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2022-2027)
- 6.3.3 North America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2027)
- 6.4 North America Alpha-fetoprotein (AFP) Tumor Market Size by Country
- 6.4.1 North America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2016-2021)
- 6.4.2 North America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2022-2027)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Alpha-fetoprotein (AFP) Tumor Market Size (2016-2027)
- 7.2 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Type
- 7.2.1 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2021)
- 7.2.2 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Type (2022-2027)
- 7.2.3 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2027)
- 7.3 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Application
- 7.3.1 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2021)
- 7.3.2 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Application (2022-2027)
- 7.3.3 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2027)
- 7.4 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Country
- 7.4.1 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Country (2016-2021)
- 7.4.2 Europe Alpha-fetoprotein (AFP) Tumor Market Size by Country (2022-2027)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size (2016-2027)
- 8.2 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Type
- 8.2.1 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2021)
- 8.2.2 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Type (2022-2027)
- 8.2.3 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2027)
- 8.3 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Application
- 8.3.1 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2021)
- 8.3.2 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Application (2022-2027)
- 8.3.3 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2027)
- 8.4 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Region
- 8.4.1 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Region (2016-2021)
- 8.4.2 Asia-Pacific Alpha-fetoprotein (AFP) Tumor Market Size by Region (2022-2027)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Alpha-fetoprotein (AFP) Tumor Market Size (2016-2027)
- 9.2 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Type
- 9.2.1 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2021)
- 9.2.2 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2022-2027)
- 9.2.3 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2027)
- 9.3 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Application
- 9.3.1 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2021)
- 9.3.2 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2022-2027)
- 9.3.3 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2027)
- 9.4 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Country
- 9.4.1 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2016-2021)
- 9.4.2 Latin America Alpha-fetoprotein (AFP) Tumor Market Size by Country (2022-2027)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size (2016-2027)
- 10.2 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Type
- 10.2.1 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2021)
- 10.2.2 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Type (2022-2027)
- 10.2.3 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Type (2016-2027)
- 10.3 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Application
- 10.3.1 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2021)
- 10.3.2 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Application (2022-2027)
- 10.3.3 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Application (2016-2027)
- 10.4 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Country
- 10.4.1 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Country (2016-2021)
- 10.4.2 Middle East & Africa Alpha-fetoprotein (AFP) Tumor Market Size by Country (2022-2027)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Abbott Laboratories Business Overview
- 11.1.3 Abbott Laboratories Alpha-fetoprotein (AFP) Tumor Introduction
- 11.1.4 Abbott Laboratories Revenue in Alpha-fetoprotein (AFP) Tumor Business (2016-2021)
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 Labcorp
- 11.2.1 Labcorp Company Details
- 11.2.2 Labcorp Business Overview
- 11.2.3 Labcorp Alpha-fetoprotein (AFP) Tumor Introduction
- 11.2.4 Labcorp Revenue in Alpha-fetoprotein (AFP) Tumor Business (2016-2021)
- 11.2.5 Labcorp Recent Development
- 11.3 Roche Diagnostics
- 11.3.1 Roche Diagnostics Company Details
- 11.3.2 Roche Diagnostics Business Overview
- 11.3.3 Roche Diagnostics Alpha-fetoprotein (AFP) Tumor Introduction
- 11.3.4 Roche Diagnostics Revenue in Alpha-fetoprotein (AFP) Tumor Business (2016-2021)
- 11.3.5 Roche Diagnostics Recent Development
- 11.4 Thermo Fisher Scientific
- 11.4.1 Thermo Fisher Scientific Company Details
- 11.4.2 Thermo Fisher Scientific Business Overview
- 11.4.3 Thermo Fisher Scientific Alpha-fetoprotein (AFP) Tumor Introduction
- 11.4.4 Thermo Fisher Scientific Revenue in Alpha-fetoprotein (AFP) Tumor Business (2016-2021)
- 11.4.5 Thermo Fisher Scientific Recent Development
- 11.5 MP Biomedicals
- 11.5.1 MP Biomedicals Company Details
- 11.5.2 MP Biomedicals Business Overview
- 11.5.3 MP Biomedicals Alpha-fetoprotein (AFP) Tumor Introduction
- 11.5.4 MP Biomedicals Revenue in Alpha-fetoprotein (AFP) Tumor Business (2016-2021)
- 11.5.5 MP Biomedicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Alpha-fetoprotein (AFP) Tumor Scope and Market Size
Alpha-fetoprotein (AFP) Tumor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-fetoprotein (AFP) Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Segment by Application
Screening and Early Detection
Diagnosis
Prognosis
Post Treatment Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Labcorp
Roche Diagnostics
Thermo Fisher Scientific
MP Biomedicals